Deutsche Bank AG Reduces Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Deutsche Bank AG trimmed its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 33.1% in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 695,877 shares of the medical equipment provider’s stock after selling 344,213 shares during the quarter. Deutsche Bank AG owned about 0.20% of Intuitive Surgical worth $203,398,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the business. State Street Corp boosted its position in Intuitive Surgical by 1.9% in the second quarter. State Street Corp now owns 14,810,625 shares of the medical equipment provider’s stock worth $5,064,345,000 after purchasing an additional 274,201 shares during the last quarter. Capital World Investors boosted its position in Intuitive Surgical by 0.5% in the second quarter. Capital World Investors now owns 7,510,586 shares of the medical equipment provider’s stock worth $2,568,118,000 after purchasing an additional 39,671 shares during the last quarter. Geode Capital Management LLC boosted its position in Intuitive Surgical by 2.6% in the second quarter. Geode Capital Management LLC now owns 6,612,636 shares of the medical equipment provider’s stock worth $2,254,459,000 after purchasing an additional 167,641 shares during the last quarter. Morgan Stanley boosted its position in Intuitive Surgical by 29.9% in the fourth quarter. Morgan Stanley now owns 5,866,613 shares of the medical equipment provider’s stock worth $1,556,706,000 after purchasing an additional 1,351,002 shares during the last quarter. Finally, Jennison Associates LLC boosted its position in Intuitive Surgical by 6.4% in the third quarter. Jennison Associates LLC now owns 4,585,190 shares of the medical equipment provider’s stock worth $1,340,205,000 after purchasing an additional 274,692 shares during the last quarter. 82.91% of the stock is currently owned by institutional investors.

Insider Activity

In other Intuitive Surgical news, President David J. Rosa sold 80,710 shares of the company’s stock in a transaction on Wednesday, February 7th. The stock was sold at an average price of $389.28, for a total value of $31,418,788.80. Following the transaction, the president now owns 163,399 shares of the company’s stock, valued at approximately $63,607,962.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Intuitive Surgical news, EVP Robert Desantis sold 867 shares of the company’s stock in a transaction on Tuesday, November 14th. The stock was sold at an average price of $290.00, for a total value of $251,430.00. Following the transaction, the executive vice president now owns 7,259 shares of the company’s stock, valued at approximately $2,105,110. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, President David J. Rosa sold 80,710 shares of the company’s stock in a transaction on Wednesday, February 7th. The shares were sold at an average price of $389.28, for a total value of $31,418,788.80. Following the completion of the transaction, the president now directly owns 163,399 shares in the company, valued at approximately $63,607,962.72. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 132,645 shares of company stock valued at $49,267,144. 0.90% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the company. HSBC assumed coverage on Intuitive Surgical in a research report on Friday, November 17th. They set a “buy” rating and a $318.00 price objective on the stock. Wells Fargo & Company lifted their price objective on Intuitive Surgical from $363.00 to $416.00 and gave the company an “overweight” rating in a research report on Friday, January 19th. Morgan Stanley boosted their price target on Intuitive Surgical from $300.00 to $330.00 and gave the stock an “equal weight” rating in a report on Monday, December 4th. Citigroup lowered their price target on Intuitive Surgical from $400.00 to $390.00 and set a “buy” rating on the stock in a report on Friday, October 20th. Finally, Raymond James boosted their price target on Intuitive Surgical from $372.00 to $435.00 and gave the stock an “outperform” rating in a report on Thursday, January 25th. Five equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $371.60.

Check Out Our Latest Analysis on ISRG

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $388.00 on Monday. The company has a market cap of $136.70 billion, a P/E ratio of 77.18, a P/E/G ratio of 6.03 and a beta of 1.37. The business’s 50 day moving average price is $348.85 and its 200-day moving average price is $313.79. Intuitive Surgical, Inc. has a fifty-two week low of $222.65 and a fifty-two week high of $392.00.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last released its earnings results on Tuesday, January 23rd. The medical equipment provider reported $1.60 earnings per share for the quarter, beating the consensus estimate of $1.48 by $0.12. The firm had revenue of $1.93 billion for the quarter, compared to the consensus estimate of $1.89 billion. Intuitive Surgical had a return on equity of 13.11% and a net margin of 25.24%. The company’s revenue for the quarter was up 16.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.91 EPS. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 4.93 EPS for the current year.

Intuitive Surgical Company Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Featured Articles

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.